Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies
Related Experiment Video
Updated: Oct 29, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
1Merck Research Laboratories, West Point, PA 19486, USA. IvanvChan@Merck.Com
Abstract:
Exact tests of equivalence and efficacy with a non-zero lower bound based on two independent binomial proportions for comparative trials are proposed. These exact tests are desirable for studies with small sample sizes. They generalize classical methods to include testing of null hypotheses of prespecified differences and can be used to demonstrate a new treatment's efficacy or its equivalence to a standard treatment. The proposed exact tests use unconditional distributions of the test statistics. Variances of test statistics are estimated via a constrained maximum likelihood method (Farrington and Manning). Data from oncology and vaccine clinical trials are used to illustrate the exact tests.
Related Concept Videos
Bioequivalence Data: Statistical Interpretation
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Equivalence: In Vitro and In Vivo Bioequivalence
Comparison Tests
Bioequivalence of Drugs: Drugs with Multiple Indications
